A new blood glucose management algorithm for Type 2 diabetes

Description

Lowering blood glucose levels in people with type 2 diabetes has clear benefits for preventing microvascular complications and potential benefits for reducing macrovascular complications and death.

Treatment needs to be individualised for each person and should start with selecting appropriate glucose and glycated haemoglobin targets, taking into account life expectancy and the patient’s wishes.

A range of recently available therapies has added to the options for lowering glucose levels, but this has made the clinical pathway for treating diabetes more complicated. This position statement from the Australian Diabetes Society outlines the risks, benefits and costs of the available therapies and suggests a treatment algorithm incorporating the older and newer agents.

 

Learning Outcomes

  1. Describe risks, benefits and costs of the available type 2 diabetes therapies and suggests a treatment algorithm incorporating the older and newer agents based on the position statement from the Australian Diabetes Society

 

Medical Audience
GP, GP Registrar, Specialist, Doctors in Training (DIT), Medical Student, International Medical Graduate, Overseas Trained Doctor

 

The Medical Journal of Australia
N/A
Reading: journal; textbook; book; literature review
1h : 0m
MBA - CPD: 1h : 0m
ACRRM - Non Fellow: 1h : 0m
ACRRM - Non Fellow: 1h : 0m
RACGP: 2 pts
General Medicine

You have to be logged in to see the content of this module.

Provided by